Why it matters: Use of GLP-1 weight loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound have skyrocketed in the last several years, with some 15.5 million people, or 6% of adults in the U.S., saying theyve tried them
These symptoms are primarily caused by damaged or impaired nerves due to long-term elevated blood sugar levels
Unlike generic diet plans or commercial weight loss gimmicks, the SYNERGY RX GLP1 treatment follows well-established medical evidence that shows how Semaglutide affects hunger signals, metabolic balance, and long-term weight regulation
Kohler et al., 2010
The market is characterized by a high degree of innovation, with continuous advancements in drug formulations, including combination therapies, to improve treatment outcomes for diabetes patients
However, despite the aforementioned studies confirming an association between GLP-1RAs and a reduced risk of AF, consensus remains elusive in current clinical research regarding whether GLP-1RAs exert antiarrhythmic effects, with some studies reporting opposing findings or no significant association